A citation-based method for searching scientific literature

Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
Times Cited: 99







List of co-cited articles
512 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


WFH Guidelines for the Management of Hemophilia, 3rd edition.
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel Carcao, Johnny Mahlangu, Margaret V Ragni, Jerzy Windyga,[...]. Haemophilia 2020
282
34

Definitions in hemophilia: communication from the SSC of the ISTH.
V S Blanchette, N S Key, L R Ljung, M J Manco-Johnson, H M van den Berg, A Srivastava. J Thromb Haemost 2014
332
20

Guidelines for the management of hemophilia.
A Srivastava, A K Brewer, E P Mauser-Bunschoten, N S Key, S Kitchen, A Llinas, C A Ludlam, J N Mahlangu, K Mulder, M C Poon,[...]. Haemophilia 2013
17

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
348
16

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
K John Pasi, Savita Rangarajan, Nina Mitchell, Will Lester, Emily Symington, Bella Madan, Michael Laffan, Chris B Russell, Mingjin Li, Glenn F Pierce,[...]. N Engl J Med 2020
149
16

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
744
15

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
15

The past and future of haemophilia: diagnosis, treatments, and its complications.
Flora Peyvandi, Isabella Garagiola, Guy Young. Lancet 2016
197
14

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington,[...]. N Engl J Med 2011
13

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
466
13

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
359
12

Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.
Sarah C Darby, Sau Wan Kan, Rosemary J Spooner, Paul L F Giangrande, Frank G H Hill, Charles R M Hay, Christine A Lee, Christopher A Ludlam, Michael Williams. Blood 2007
353
12

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
Johnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, Claude Negrier, Markus Niggli, M Elisa Mancuso, Christophe Schmitt, Victor Jiménez-Yuste, Christine Kempton, Christophe Dhalluin,[...]. N Engl J Med 2018
282
11

Men with severe hemophilia in the United States: birth cohort analysis of a large national database.
Marshall A Mazepa, Paul E Monahan, Judith R Baker, Brenda K Riske, J Michael Soucie. Blood 2016
71
15

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Johnny Mahlangu, Jerry S Powell, Margaret V Ragni, Pratima Chowdary, Neil C Josephson, Ingrid Pabinger, Hideji Hanabusa, Naresh Gupta, Roshni Kulkarni, Patrick Fogarty,[...]. Blood 2014
308
10

The cost of severe haemophilia in Europe: the CHESS study.
Jamie O'Hara, David Hughes, Charlotte Camp, Tom Burke, Liz Carroll, Daniel-Anibal Garcia Diego. Orphanet J Rare Dis 2017
59
16

Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Wolfgang Miesbach, Karina Meijer, Michiel Coppens, Peter Kampmann, Robert Klamroth, Roger Schutgens, Marco Tangelder, Giancarlo Castaman, Joachim Schwäble, Halvard Bonig,[...]. Blood 2018
153
8

The hemophilias--from royal genes to gene therapy.
P M Mannucci, E G Tuddenham. N Engl J Med 2001
675
7


Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
Catherine S Manno, Glenn F Pierce, Valder R Arruda, Bertil Glader, Margaret Ragni, John J Rasko, Margareth C Ozelo, Keith Hoots, Philip Blatt, Barbara Konkle,[...]. Nat Med 2006
7

A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
A Gringeri, B Lundin, S von Mackensen, L Mantovani, P M Mannucci. J Thromb Haemost 2011
331
7

Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study.
I Plug, J G Van Der Bom, M Peters, E P Mauser-Bunschoten, A De Goede-Bolder, L Heijnen, C Smit, J Willemse, F R Rosendaal. J Thromb Haemost 2006
218
7

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B.
J Michael Soucie, Paul E Monahan, Roshni Kulkarni, Barbara A Konkle, Marshall A Mazepa. Blood Adv 2018
40
17


Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, Doyoung Lee, Samira Rabbanian, Deepak Raj, Nishil Patel, Edward G D Tuddenham, Olivier D Christophe, John H McVey,[...]. Blood 2013
177
7

Hemophilia therapy: the future has begun.
Pier Mannuccio Mannucci. Haematologica 2020
57
12

New therapies for hemophilia.
Angela C Weyand, Steven W Pipe. Blood 2019
65
10

The benefits of prophylaxis in patients with hemophilia B.
Giancarlo Castaman. Expert Rev Hematol 2018
19
36


Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients.
Jerry S Powell, Neil C Josephson, Doris Quon, Margaret V Ragni, Gregory Cheng, Ella Li, Haiyan Jiang, Lian Li, Jennifer A Dumont, Jaya Goyal,[...]. Blood 2012
157
6

Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.
Midori Shima, Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Tetsuji Sato, Katsuyuki Fukutake, Naoki Fukazawa, Koichiro Yoneyama, Hiroki Yoshida, Keiji Nogami. N Engl J Med 2016
241
6


Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
K John Pasi, Savita Rangarajan, Pencho Georgiev, Tim Mant, Michael D Creagh, Toshko Lissitchkov, David Bevan, Steve Austin, Charles R Hay, Inga Hegemann,[...]. N Engl J Med 2017
191
6

Inhibitor development and mortality in non-severe hemophilia A.
C L Eckhardt, J I Loomans, A S van Velzen, M Peters, E P Mauser-Bunschoten, R Schwaab, M G Mazzucconi, A Tagliaferri, B Siegmund, S E Reitter-Pfoertner,[...]. J Thromb Haemost 2015
38
15

Hemophilia A and B: molecular and clinical similarities and differences.
Giancarlo Castaman, Davide Matino. Haematologica 2019
28
21

Achieving the unimaginable: Health equity in haemophilia.
Mark W Skinner, Diane Nugent, Pam Wilton, Brian O'Mahony, Gerry Dolan, Jamie O'Hara, Erik Berntorp. Haemophilia 2020
24
25

First-year results of an expanded humanitarian aid programme for haemophilia in resource-constrained countries.
G F Pierce, A Haffar, G Ampartzidis, F Peyvandi, S Diop, M El-Ekiaby, H M van den Berg. Haemophilia 2018
22
27

Joint disease in haemophilia: Pathophysiology, pain and imaging.
L F D van Vulpen, K Holstein, C Martinoli. Haemophilia 2018
45
13

Occurrence rates of haemophilia among males in the United States based on surveillance conducted in specialized haemophilia treatment centres.
John Michael Soucie, Connie H Miller, Brandi Dupervil, Binh Le, Tyler W Buckner. Haemophilia 2020
19
31

Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B.
Jerry S Powell, K John Pasi, Margaret V Ragni, Margareth C Ozelo, Leonard A Valentino, Johnny N Mahlangu, Neil C Josephson, David Perry, Marilyn J Manco-Johnson, Shashikant Apte,[...]. N Engl J Med 2013
232
6

Recombinant factor VIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A.
G Young, J Mahlangu, R Kulkarni, B Nolan, R Liesner, J Pasi, C Barnes, S Neelakantan, G Gambino, L M Cristiano,[...]. J Thromb Haemost 2015
108
5

Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice.
Stuart Bunting, Lening Zhang, Lin Xie, Sherry Bullens, Rajeev Mahimkar, Sylvia Fong, Krystal Sandza, Danielle Harmon, Bridget Yates, Britta Handyside,[...]. Mol Ther 2018
29
17

Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX.
Angiola Rocino, Massimo Franchini, Antonio Coppola. J Clin Med 2017
35
14

Haemophilia patients' unmet needs and their expectations of the new extended half-life factor concentrates.
S von Mackensen, W Kalnins, J Krucker, J Weiss, W Miesbach, M Albisetti, I Pabinger, J Oldenburg. Haemophilia 2017
35
14

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A.
Barbara A Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David H Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone,[...]. Blood 2015
156
5


Mortality and causes of death in Italian persons with haemophilia, 1990-2007.
A Tagliaferri, G F Rivolta, A Iorio, E Oliovecchio, M E Mancuso, M Morfini, A Rocino, M G Mazzucconi, M Franchini, N Ciavarella,[...]. Haemophilia 2010
123
5

Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
Steven W Pipe, Midori Shima, Michaela Lehle, Amy Shapiro, Sammy Chebon, Katsuyuki Fukutake, Nigel S Key, Agnès Portron, Christophe Schmitt, Maria Podolak-Dawidziak,[...]. Lancet Haematol 2019
131
5

Clinical severity of haemophilia A: does the classification of the 1950s still stand?
I E M Den Uijl, E P Mauser Bunschoten, G Roosendaal, R E G Schutgens, D H Biesma, D E Grobbee, K Fischer. Haemophilia 2011
152
5

The definition, diagnosis and management of mild hemophilia A: communication from the SSC of the ISTH.
M Makris, J Oldenburg, E P Mauser-Bunschoten, K Peerlinck, G Castaman, K Fijnvandraat. J Thromb Haemost 2018
28
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.